Virtu Financial’s Spruce Biosciences SPRB Stock Holding History

Virtu Financial’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-526	Closed	-$11K	–	2205
2025 Q1	$11K	Buy	+526	New	+$14.7K	﹤0.01%	1176
2023 Q2	–	Sell	-183	Closed	-$30K	–	2161
2023 Q1	$30K	Buy	+183	New	+$34K	﹤0.01%	1171
2022 Q3	–	Sell	-210	Closed	-$27K	–	2333
2022 Q2	$27K	Buy	+210	New	+$26.9K	﹤0.01%	1274

Other funds holding SPRB

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

CSC

Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return

Virtu Financial's SPRB Position: Q2 2025 in Review

Virtu Financial sold out of Spruce Biosciences (SPRB) in Q2 2025, closing a stake of 526 shares — an estimated $11K sold.

Virtu Financial first reported a position in SPRB in Q2 2022 and held it in 3 quarters. The position peaked at $30K in Q1 2023. 3 funds tracked by Wall St. Rank hold SPRB as of Q2 2025.

Virtu Financial reported no remaining Spruce Biosciences position as of Q2 2025 after selling out during the quarter.
Virtu Financial sold 526 Spruce Biosciences shares in Q2 2025, an estimated $11K.
Virtu Financial first reported a position in Spruce Biosciences in Q2 2022 and held it in 3 quarters.
Virtu Financial's Spruce Biosciences position peaked at $30K in Q1 2023.
3 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.